Barbara Pasini

15.3k total citations · 2 hit papers
92 papers, 5.4k citations indexed

About

Barbara Pasini is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Barbara Pasini has authored 92 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Genetics and 23 papers in Surgery. Recurrent topics in Barbara Pasini's work include BRCA gene mutations in cancer (12 papers), Adrenal and Paraganglionic Tumors (10 papers) and Cancer Genomics and Diagnostics (9 papers). Barbara Pasini is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Adrenal and Paraganglionic Tumors (10 papers) and Cancer Genomics and Diagnostics (9 papers). Barbara Pasini collaborates with scholars based in Italy, United States and France. Barbara Pasini's co-authors include Isabella Ceccherini, Giovanni Romeo, Yin Luo, Constantine A. Stratakis, Renata Bocciardi, Robert M.W. Hofstra, Tineke Stelwagen, Rein P. Stulp, Rudy M. Landsvater and Hans Kristian Ploos van Amstel and has published in prestigious journals such as Nature, The Lancet and Nature Genetics.

In The Last Decade

Barbara Pasini

87 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1994 872 citations Isabella Ceccherini, Yin Luo et al. profile →
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

1994 532 citations Giovanni Romeo, Yin Luo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Pasini Italy	34	2.0k	1.8k	1.4k	1.3k	1.1k	92	5.4k
Jan Zedenius Sweden	39	1.5k 0.8×	1.5k 0.8×	836 0.6×	3.0k 2.3×	1.4k 1.3×	146	5.2k
Kennichi Kakudo Japan	49	2.3k 1.2×	2.1k 1.2×	1.2k 0.8×	3.9k 3.0×	2.1k 1.9×	284	7.8k
Lawrence S. Kirschner United States	36	1.6k 0.8×	2.0k 1.1×	431 0.3×	1.5k 1.1×	1.5k 1.4×	100	5.4k
Oliver Gimm Germany	47	2.1k 1.1×	3.3k 1.9×	780 0.6×	3.8k 2.9×	1.4k 1.3×	166	7.4k
Cristina Romei Italy	42	1.8k 0.9×	1.4k 0.8×	1.2k 0.9×	4.9k 3.7×	1.7k 1.6×	122	6.5k
José Cameselle‐Teijeiro Spain	39	1.6k 0.8×	638 0.4×	545 0.4×	1.7k 1.3×	1.6k 1.5×	143	4.3k
Natalia S. Pellegata Germany	33	1.5k 0.8×	963 0.5×	341 0.2×	1.3k 1.0×	1.8k 1.6×	94	4.3k
Zhaowen Zhu United States	29	2.4k 1.2×	904 0.5×	900 0.6×	3.6k 2.8×	2.2k 2.0×	42	6.1k
David G. McFadden United States	21	2.0k 1.0×	643 0.4×	581 0.4×	1.1k 0.9×	582 0.5×	36	3.6k
Friedhelm Raue Germany	44	1.5k 0.8×	2.1k 1.2×	1.1k 0.8×	4.4k 3.4×	2.0k 1.8×	237	7.4k

Countries citing papers authored by Barbara Pasini

Since Specialization

Citations

This map shows the geographic impact of Barbara Pasini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pasini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pasini more than expected).

Fields of papers citing papers by Barbara Pasini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Pasini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pasini. The network helps show where Barbara Pasini may publish in the future.

Co-authorship network of co-authors of Barbara Pasini

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Pasini. A scholar is included among the top collaborators of Barbara Pasini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Pasini. Barbara Pasini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carbone, Antonino, Silvia Giordano, Paolo Fava, et al.. (2025). Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes. Diseases. 13(6). 180–180.

Tetti, Martina, Jacopo Burrello, Marguerite Hureaux, et al.. (2024). Prevalence of Hyperkalemia and Familial Hyperkalemic Hypertension in 5100 Patients Referred to a Tertiary Hypertension Unit. Hypertension. 81(11). 2275–2285.

Smirne, Carlo, Alessandro Maria Berton, Barbara Pasini, et al.. (2024). A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. Journal of Endocrinological Investigation. 47(7). 1815–1825. 3 indexed citations

Faleschini, Michela, et al.. (2023). Phenotype reversion as “natural gene therapy” in Fanconi anemia by a gene conversion event. Frontiers in Genetics. 14. 1240758–1240758.

Roccuzzo, Gabriele, Martina Merli, Gianluca Avallone, et al.. (2022). BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: a novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome. Melanoma Research. 32(5). 390–392. 2 indexed citations

Berrino, Enrico, Roberto Filippi, Elisabetta Fenocchio, et al.. (2022). Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. npj Precision Oncology. 6(1). 15–15. 12 indexed citations

Gambale, Antonella, Roberta Russo, Immacolata Andolfo, et al.. (2019). Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition. Clinical Genetics. 96(4). 359–365. 14 indexed citations

Tetti, Martina, Silvia Monticone, Jacopo Burrello, et al.. (2018). Liddle Syndrome: Review of the Literature and Description of a New Case. International Journal of Molecular Sciences. 19(3). 812–812. 65 indexed citations

Miglio, Umberto, Enrico Berrino, Giulio Ferrero, et al.. (2018). The expression of LINE1‐MET chimeric transcript identifies a subgroup of aggressive breast cancers. International Journal of Cancer. 143(11). 2838–2848. 19 indexed citations

10.

Gironi, Laura Cristina, Enrico Colombo, Barbara Pasini, et al.. (2018). Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers. Archives of Dermatological Research. 310(10). 769–784. 8 indexed citations

11.

Biglia, Nicoletta, Paola Sgandurra, Valentina Elisabetta Bounous, et al.. (2016). Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival. ecancermedicalscience. 10. 639–639. 28 indexed citations

12.

Xekouki, Paraskevi, Karel Pacák, Madson Q. Almeida, et al.. (2011). Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH?. The Journal of Clinical Endocrinology & Metabolism. 97(3). E357–E366. 113 indexed citations

13.

Raygada, Margarita, Barbara Pasini, & Constantine A. Stratakis. (2011). Hereditary Paragangliomas. Advances in oto-rhino-laryngology. 70. 99–106. 16 indexed citations

14.

Foulkes, William D., Nancy Hamel, Barbara Pasini, et al.. (2011). Extending the phenotypes associated withDICER1mutations. Human Mutation. 32(12). 1381–1384. 143 indexed citations

15.

Aiello, Antonella, Paola Collini, Maria Gullo, et al.. (2005). The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case. Surgery. 137(5). 574–576. 7 indexed citations

16.

Palo, Giuseppe De, Luigi Mariani, Tiziana Camerini, et al.. (2002). Effect of Fenretinide on Ovarian Carcinoma Occurrence. Gynecologic Oncology. 86(1). 24–27. 74 indexed citations

17.

Narod, Steven A., Parviz Ghadirian, Mark E. Robson, et al.. (2000). Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. The Lancet. 356(9245). 1876–1881. 388 indexed citations

18.

Pasini, Barbara & Marco A. Pierotti. (1999). Familial Breast and Ovarian Cancer: Genetic Counseling and Clinical Management in Italy. Disease Markers. 15(1-3). 41–43. 1 indexed citations

19.

Ceccherini, Isabella, Barbara Pasini, Furio Pacini, et al.. (1997). Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene. Oncogene. 14(21). 2609–2612. 29 indexed citations

20.

Luo, Yin, Isabella Ceccherini, Barbara Pasini, et al.. (1993). Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Human Molecular Genetics. 2(11). 1803–1808. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact